未登录

B

Bingtian Xu

South China University of Technology

H指数:11

被引数:506

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

OAC1 improves mitofusin 2 expression to alleviate neuronal injury following experimental ischemic stroke

KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

IF2.2

2025-11-010

PRE

Harnessing Patient-Derived Antibodies-Induced Microglial Complement 1q Expression: A Novel Therapeutic Approach for Anti-NMDAR Encephalitis

利用患者源性抗体诱导的小胶质细胞补体1q表达：一种抗NMDAR脑炎的新型治疗策略

Molecular Therapy

IF12

2025-08-060

PRE

TDP43 augments astrocyte inflammatory activity through mtDNA-cGAS-STING axis in NMOSD

TDP43通过mtDNA-cGAS-STING轴增强NMOSD中星形胶质细胞的炎症活性。

JOURNAL OF NEUROINFLAMMATION

IF10.1

2025-01-220

OA

Mitofusin-2 mediates cannabidiol-induced neuroprotection against cerebral ischemia in rats

ACTA PHARMACOLOGICA SINICA

IF8.4

2022-10-1314

OA

Mitofusin 2 confers the suppression of microglial activation by cannabidiol: Insights from in vitro and in vivo models

BRAIN BEHAVIOR AND IMMUNITY

IF7.6

2022-08-0120

PRE

Roflumilast, a cyclic nucleotide phosphodiesterase 4 inhibitor, protects against cerebrovascular endothelial injury following cerebral ischemia/reperfusion by activating the Notch1/Hes1 pathway

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2022-07-017

PRE

Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathway

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2021-02-0166

PREAI

Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway

IF11.9

2020-01-0192

OAAI

Inhibition of PDE4 Attenuates TNF-α-Triggered Cell Death Through Suppressing NF-κB and JNK Activation in HT-22 Neuronal Cells

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2019-10-2823

PREAI

Inhibition of PDE4 by FCPR16 induces AMPK-dependent autophagy and confers neuroprotection in SH-SY5Y cells and neurons exposed to MPP+-induced oxidative insult

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2019-05-0144

PREAI

FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK313/ β-catenin signaling pathway

BIOCHEMICAL PHARMACOLOGY

IF5.6

2019-05-0154

PREAI